Value Hive
Value Hive

Q4 Investor Letter Audibles: Greenhaven Road, Laughing Water Capital, & Greenlight Capital

Hey guys! This week I'm trying something brand new on the podcast. I created an "audiobook" edition of some of my favorite hedge fund letters. This week, I read the Q4 letters from the following funds: * Greenhaven Road Capital * Laughing Water Capital * Greenlight Capital There is on

Featured Speakers

Brandon Beylo Host

Topics Discussed

Episode Summary

Executive Summary: The episode is a curated reading of Q4 2021 investor letters from Greenhaven Road, Laughing Water Capital, and Greenlight Capital. Across the letters, the managers argue that volatility, inflation, and rising rates are creating mispricings, while long-duration quality businesses, special situations, and selective value names still offer strong multi-year upside.

Main Topics: Macro backdrop: inflation, rates, and volatility (Priority: 5/5): All three letters frame the market as being driven by inflation concerns, rising interest rates, and sharp factor rotations. The managers argue that short-term drawdowns can obscure long-term fundamentals and create better entry points. Growth investing amid multiple compression (Priority: 5/5): Scott Miller emphasizes that growth can still work even if valuations compress, provided the business can sustain durable growth and reinvest capital efficiently. Idiosyncratic long ideas and operating catalysts (Priority: 5/5): Laughing Water and Greenhaven both highlight businesses with structural or operational catalysts, such as asset-light transitions, cross-selling, buybacks, and product expansion. Value versus growth as a spectrum (Priority: 4/5): Matt Sweeney argues against rigid style labels and prefers a diversified portfolio across the value-growth spectrum, focusing on situations where growth is underappreciated or value is hidden by complexity. Short book and bubble exposure (Priority: 4/5): Greenlight discusses profitable shorts in bubble names, innovation/speculation themes, and other overvalued stocks that remain vulnerable despite the selloff. Special situations and corporate actions (Priority: 4/5): Several investments depend on sales, spin-offs, buybacks, restructurings, or regulatory change, including Countryside, ODP, Amia, and cannabis-related names. Sponsor segment and episode format (Priority: 2/5): The host explains this episode is an audio-format experiment compiling public investor letters, sponsored by Quarter, Metimco, and Tegus.

Key Arguments: Multiple compression does not eliminate the case for growth if revenue can compound at high rates for years. Companies with long runways, operating leverage, and low capital intensity can still generate strong returns even in a rising-rate environment. A portfolio should not be tied to one style factor; opportunities exist across both asset-based value and underappreciated growth. Mispriced stocks often arise from temporary operational issues, structural misunderstandings, or misleading financial statements. Large, scaled platforms like KKR, Teladoc, and Greenlight’s payment/tech holdings can benefit from distribution, cross-selling, and market leadership. Special situations such as buybacks, divestitures, potential IPOs, and legal/regulatory changes can unlock value faster than the market expects. Bubble stocks and weak speculative names can still be short candidates even after large declines, because valuation remains detached from fundamentals.

Data Points: Greenhaven Q4 return: approximately -9% net - Scott Miller’s fund return for the fourth quarter of 2021 Greenhaven full-year return: approximately +3% net - Scott Miller’s fund return for 2021 PAR Technologies ARR per share: doubled in 2021 - Underlying business performance despite share-price decline Digital Turbine starting multiple: less than 8x this year's expected gross profits - Used to justify growth upside PAR valuation: approximately $1 billion - Scott Miller’s estimate after backing out profitable hardware/defense businesses PAR recurring revenue multiple: roughly 6x 2022 year-end recurring revenue - After adjustments and expected growth above 30% KKR fee-paying AUM: $350 billion - Basis for expected revenue growth from retail and insurance products Teladoc valuation: a touch over $10 billion - Valued at less than 5x this year's revenues and less than 4x next year's revenues Teladoc end-customer base: 76 million - Scale advantage for product development and spread of investment costs Cellebrite gross margins: 80% - Supports strong economics in digital intelligence business Cellebrite NRR: over 140% - Shows strong expansion within installed base Laughing Water 4Q return: less than 1% - Class A shares performance in Q4 2021 Laughing Water full-year return: approximately 39% - 2021 performance for Class A shares Laughing Water since inception CAGR: 29% - Six-year track record cited by Matt Sweeney Countryside partnership plots: more than 53,000 - Equivalent to about 10 years of delivery at current rates Cannabis thesis timeframe: within the next year or three - Expected federal legalization or imminent legalization perception in the U.S. Greenlight 2021 return: 11.9% - Net return for the Green Light Capital partnerships in 2021 Greenlight cumulative return since inception: 1,882.6% - Since May 1996, net of fees and expenses Greenlight annualized return since inception: 12.3% - Net annualized return since May 1996 Greenlight investor gains since inception: $4.7 billion - Net of fees and expenses Greenlight Q4 return: 18.6% - Fourth quarter 2021 performance Greenlight long exposure: 127% - Average long exposure at quarter end Greenlight short exposure: 71% - Average short exposure at quarter end Rivian valuation at peak: $162 billion - Greenlight notes the IPO and hedging of its position Danimer Scientific decline: from $16.54 to $8.52 - Q4 detractor due to capital structure mishandling Global Payments valuation: 13x consensus expected 2022 earnings per share - Entry price described as attractive for a high-quality payments business

Pivotal Quotes: "If we can find the right combination of reasonable price and the ability to sustain growth, we can do quite well over time, even with multiple compression." — Scott Miller: Greenhaven Road Capital letter explaining why growth still works in a rising-rate environment "What I don't want to have is a portfolio of roughly 15 stocks that appears to be reasonably diversified, while in fact all 15 of those stocks are different takes on the same bet." — Matt Sweeney: Laughing Water Capital on portfolio construction across the value-growth spectrum "Inflation is like toothpaste. Once it's out, you can hardly get it back in." — Carl Otto Pohl (quoted by David Einhorn): Greenlight Capital’s closing remark on the persistence of inflation

Implications: The letters suggest investors should expect continued volatility, favor businesses with durable growth and balance-sheet strength, and look for catalysts, not just cheap multiples. Style rigidity is risky; patience and selectivity may matter more than timing.

🔓 Sign Up for Unlimited Episode Search

About Value Hive

Welcome to The Hive! It's nice in here, isn't it? The Hive is a collection of investors, entrepreneurs, thinkers and individuals dedicated to getting a little smarter each day. If you're a fan of value investing, business models, eclectic success and failure stories -- this is your podcast. Our goal is to provide you the highest quality interviews with new twists on old topics. Fresh perspectives on antiquated ideas. Passionate discourse on all things investing. Join us as we strive to improve a little bit each day: https://macro-ops.com/

View all episodes from Value Hive